-
Antengene Appoints Amily Zhang as its Chief Medical Officer
07 Dec 2022 06:02 GMT
… obtained multiple Investigational New Drug (IND) approvals in … clinical development and medical affairs in the pharmaceutical industry, and … in the registration of Exjade® and Nexavar®, as … class therapeutics for the treatment of hematologic malignancies and …
-
Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
07 Jun 2022 08:23 GMT
… adhere well to prescribed drug treatment.47 Patients who … sessions with his doctor and specialist nurse … Therapeutics plc, and Agios Pharmaceuticals Ltd, outside the submitted … and accounting for medication adherence in clinical trials. Clin Pharmacol …
-
Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz
26 Oct 2021 06:57 GMT
… global leader in generic pharmaceuticals and biosimilars. Its global … knee NIS793 Granted FDA orphan drug designation in combination … cancer Results from ongoing trials and other highlights … create transformative treatments in areas of great medical need. In …
-
Novartis Pharmaceuticals Agrees to Pay $678M to Settle Doctor-Bribe Claims
02 Jul 2020 15:30 GMT
… sales of its Exjade and Myfortic drugs. Exjade reduces iron levels … doctors to choose the best treatment for their patients and increases drug … charitable foundations to pay Medicare patients’ co-pays in … is US v. Novartis Pharmaceutical Corp., 11-cv-0071, …
-
Novartis to pay $678 million to settle doctor-bribe claims
02 Jul 2020 08:45 GMT
… set to go to trial last year before being … sales of its Exjade and Myfortic drugs. Exjade reduces iron levels … doctors to choose the best treatment for their patients and increases drug … three charitable foundations to pay Medicare patients’ co-pays in …
-
Immunomedics Gets Early FDA Approval - Path To Profitability Still Treacherous
28 Apr 2020 15:49 GMT
… from the FDA for Trodelvy (sacituzumab govitecan) for the treatment of … 39;s Antibody Drug Conjugate (ADC) Trodelvy, The trial was for third … on reps who visited doctor';s offices in a … plan. Semerjian is an experienced biotech executive with a track record …
-
Bristol Myers/Acceleron's Reblozyl Label Expansion Gets FDA Nod
07 Apr 2020 08:47 GMT
… aamt).
The drug has been approved for the treatment of anemia … (“MAA”) to the European Medicines Agency (EMA). The MAA … oral iron chelating agents Exjade and Jadenu.Both Bristol … for outperformance. Our recent biotech recommendations have produced gains of …
-
Global Iron Metabolism Disorders Drugs Market worth US$ XX Billion by 2029
11 Jan 2020 20:07 GMT
… copy of Iron Metabolism Disorders Drugs Market : https:// … : In 2013, Novartis drug Exjade first treatment got approved by FDA for chronic iron … , Cipla Ltd., ApoPharma Inc., Teva Pharmaceutical Industries Limited, Sun Pharma Industries …
-
Glenmark Pharmaceuticals receives ANDA approval for Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg
07 Jan 2020 11:12 GMT
… States Food & Drug Administration (U.S. FDA) for Deferasirox Tablets … the generic version of Exjade®1 Tablets for Oral … 500 mg, of Novartis Pharmaceuticals Corporation.
According to IQVIA™ … ending November 2019, the Exjade® Tablets for Oral Suspension, …